19th Dec 2008 17:53
RNS Number : 5530K
AGI Therapeutics plc
19 December 2008
AGI Therapeutics plc ('AGI' or the 'Company')
Holding in Company
AGI was notified on 19 December 2008 that following a disposal of ordinary shares, Gartmore Investment Limited no longer has a notifiable interest in the issued share capital of the Company.
Contact Information
AGI Therapeutics
David G. Kelly, Chief Financial Officer Tel: +353 1 449 3254
This information is provided by RNS
The company news service from the London Stock Exchange
Related Shares:
Potentially Ai